MTACW
Closed
Medtech Acquisition Corporation
0.218
+0.038 (+21.11%)
Last Update: 10 Aug 2023 23:00:00
Yesterday: 0.18
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.061
MedTech Acquisition Corporation is a special purpose acquisition company (SPAC) that was formed in 2020 for the purpose of acquiring one or more businesses in the medical technology industry. The company is listed on the NASDAQ stock exchange under the ticker symbol MTACU.
MedTech Acquisition Corporation was founded by Kevin M. Conroy, who is the CEO of Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests. The company's management team includes several executives with extensive experience in the medical technology industry.
The company raised $150 million in its initial public offering (IPO) in October 2020. The funds raised from the IPO will be used to acquire a target company in the medical technology industry.
MedTech Acquisition Corporation has not yet announced any potential acquisition targets, but the company has stated that it is focused on acquiring businesses that are developing innovative medical technologies that have the potential to transform healthcare.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
MedTech Acquisition Corporation was founded by Kevin M. Conroy, who is the CEO of Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests. The company's management team includes several executives with extensive experience in the medical technology industry.
The company raised $150 million in its initial public offering (IPO) in October 2020. The funds raised from the IPO will be used to acquire a target company in the medical technology industry.
MedTech Acquisition Corporation has not yet announced any potential acquisition targets, but the company has stated that it is focused on acquiring businesses that are developing innovative medical technologies that have the potential to transform healthcare.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








